Bulanon, Austin A.

HRN: 58  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2022
AMPICILLIN 500MG (VIAL)
10/13/2022
10/20/2022
IV
175mg
Q6hours
AGE With Moderate Dehydration
Waiting Final Action 
10/13/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/13/2022
10/20/2022
IV
80mg
Q8hours
Amoebiasis
Waiting Final Action 
10/14/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/14/2022
10/21/2022
PO
2.5ml
Tid
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: